clinical trial retatrutide A new from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes retatrutide clinical trials retatrutide parkinson's

These findings expand upon the growing body of literature raising concerns regarding the potential ocular safety of systemic GLP-1 RA use in patients with diabetes, investigators concluded

For long-term storage before use, refrigeration is always the best practice

Children weighing 65 kg or less can drink up to 3 mL/kg per hour of clear fluids such as water, pulp-free juice and carbohydrate drinks until they are called into the operating theatre

Psychiatrists (MD/DO) have full prescriptive authority to prescribe FDA-approved medications including GLP-1 agonists like semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) for weight loss, provided they follow standard of care and any state-specific rules

#GLP1 #GLP1ReceptorAgonists #ObesityTreatment #WeightLossDrugs #MetabolicHealth #DiabetesCare #Pharmaceuticals #Biotechnology #HealthcareInnovation #LifeSciences #NovoNordisk #EliLilly #MarketResearch To view or add a comment, sign in Three companies will walk on stage at ADA this week and claim the obesity market

Can I build muscle while taking Ozempic or Wegovy